GLOBUS MEDICAL INC
GLOBUS MEDICAL INC
AUDUBON, PA
Loading...
Price History
Market Data
| Market Cap | 12.19B |
| P/E Ratio | 22.94 |
| P/B Ratio | 2.67 |
| EPS | 3.93 |
| Dividend Yield | - |
| D/E Ratio | 0.16 |
| Current Ratio | 4.26 |
| Currency | USD |
Key Financial Metrics
2.94B
Revenue
537.87M
Net Income
3.93
EPS (Diluted)
902.47M
Free Cash Flow
Profitability
Gross Margin
67.4%
Operating Margin
16.3%
Net Profit Margin
18.3%
EBITDA
959.44M
Returns & Efficiency
Return on Assets (ROA)
10.1%
Return on Equity (ROE)
11.8%
Dividend Yield
-
EPS
3.93
Financial Health
Total Assets
5.30B
Total Debt
-
Debt to Equity
0.16x
Current Ratio
4.26
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Measuring, Analyzing & Controlling Instruments |
| HQ | AUDUBON, PA |
| Fiscal Year | 2025 |
Peers
STRYKER CORP
SYK
113.24B
P/E: --
3M CO
MMM
86.42B
P/E: --
83.53B
P/E: --
41.26B
P/E: --
RESMED INC
RSMDF
37.64B
P/E: --
DEXCOM INC
DXCM
22.94B
P/E: --
21.69B
P/E: 35.1
PENUMBRA INC
PEN
12.76B
P/E: 85.5
Quick Links
Financial Statistics
Valuation
Market Cap$12.19B
P/E Ratio (TTM)22.9
Price to Book2.67
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin67.4%
Operating Margin16.3%
Net Margin18.3%
ROE11.8%
ROA10.1%
Leverage & Liquidity
Debt to Equity0.16
Current Ratio4.26
Total Debt-
Total Assets$5.30B
Stockholders' Equity$4.57B
Income Statement (FY 2025)
Revenue$2.94B
Gross Profit$1.98B
Operating Income$479.82M
Net Income$537.87M
EPS (Diluted)$3.93
Cash Flow (FY 2025)
Free Cash Flow$902.47M
Cash & Equivalents$526.16M
Revenue Growth16.7%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 2560 GENERAL ARMISTEAD AVENUE AUDUBON, PA 19403 |
| Phone | 610-930-1800 |
| Incorporated | DE, US |
| EIN | 043744954 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 135.25M |
| Stockholders' Equity | $4.57B |
| Cash & Equivalents | $526.16M |
Recent Filings
View All
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-30
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-14
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-03-26
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-02-25
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-02-24
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-24
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-17
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-02-12
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-11-06
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-08-07
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-05-08
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2025-04-25
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2025-02-20
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-11-05
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-08-06
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | GLOBUS MEDICAL INC |
| Ticker | GMED |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Measuring, Analyzing & Controlling Instruments |
| Headquarters | AUDUBON, PA |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 12.19B |
| Revenue | 2.94B |
| Net Income | 537.87M |
| P/E Ratio | 22.94 |
| EPS | 3.93 |
| Net Margin | 18.3% |
| ROE | 11.8% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...